A register-based cohort study on the effectiveness and Safety of anti-PCSK9 treatment in persons with hyperlipidemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A register-based cohort study on the effectiveness and Safety of anti-PCSK9 treatment in persons with hyperlipidemia ; volume:4 ; number:1 ; day:7 ; month:10 ; year:2024 ; pages:1-8 ; date:12.2024
Communications medicine ; 4, Heft 1 (7.10.2024), 1-8, 12.2024
- Creator
-
Andersen, Michael Asger
Helms Andreasen, Anne
Evi Bang, Lia
Jimenez-Solem, Espen
Petersen, Tonny Studsgaard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-024-00611-x
- URN
-
urn:nbn:de:101:1-2412242104429.758630667826
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andersen, Michael Asger
- Helms Andreasen, Anne
- Evi Bang, Lia
- Jimenez-Solem, Espen
- Petersen, Tonny Studsgaard
- SpringerLink (Online service)
Other Objects (12)
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis
Gene Therapy Targeting PCSK9
CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration
Synthesis of a PCSK9 Inhibitor
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Monoklonale Antikörper gegen PCSK9 : eine Erfolgsgeschichte
Hyperlipidemia : bringing clarity to lipid management
Dendritic cells in hyperlipidemia associated atherosclerosis
Hyperlipidemia, statin use and dengue severity
PCSK9 targets important for lipid metabolism
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis
Gene Therapy Targeting PCSK9
CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration
Synthesis of a PCSK9 Inhibitor
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Monoklonale Antikörper gegen PCSK9 : eine Erfolgsgeschichte
Hyperlipidemia : bringing clarity to lipid management
Dendritic cells in hyperlipidemia associated atherosclerosis
Hyperlipidemia, statin use and dengue severity
PCSK9 targets important for lipid metabolism
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis
Gene Therapy Targeting PCSK9
CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration
Synthesis of a PCSK9 Inhibitor
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Monoklonale Antikörper gegen PCSK9 : eine Erfolgsgeschichte
Hyperlipidemia : bringing clarity to lipid management
Dendritic cells in hyperlipidemia associated atherosclerosis
Hyperlipidemia, statin use and dengue severity